Related by context. All words. (Click for frequent words.) 72 Receptos 72 Portola Pharmaceuticals 71 Vaccinex 71 VentiRx 71 Agios Pharmaceuticals 71 PDE4 inhibitor 71 FoldRx Pharmaceuticals Inc. 71 volociximab 70 Mersana 70 Aerovance 70 Galenea 70 Adenosine Therapeutics 70 Lycera 70 Dynogen 69 JAK1 69 Gemin X 69 Creabilis Therapeutics 69 Quark Biotech 69 Tobira Therapeutics 69 Catalyst Biosciences 69 Taligen 69 Bayhill Therapeutics 69 TolerRx 69 FoldRx 69 immatics 69 cathepsin K inhibitor 69 TargeGen 69 JAK inhibitor 69 PF # [002] 69 Pervasis 69 Enzo Therapeutics 69 Quark Pharmaceuticals 69 Taligen Therapeutics 68 VisEn Medical 68 Cerimon 68 KAI Pharmaceuticals 68 QuatRx 68 OncoMed 68 Alnara Pharmaceuticals 68 ViroChem Pharma Inc. 68 Hybridon 68 ChemoCentryx 68 Ambrx 68 Celator 68 Regulus Therapeutics 68 Relypsa 68 Angioblast 68 Anchor Therapeutics 68 Eckard Weber 68 elbion 68 VentiRx Pharmaceuticals 68 Ceregene 68 Syntonix 68 ESBATech 68 Versartis 68 targeted radiotherapeutic 68 Arno Therapeutics 68 Acuity Pharmaceuticals 68 Allozyne 68 Inotek 67 Intellikine 67 rxRNA 67 Anaphore 67 Vegenics 67 Therion Biologics 67 Osiris Therapeutics 67 GSK '# 67 Tolerx 67 Fovea Pharmaceuticals 67 Omthera 67 Initiates Clinical 67 AGTC 67 Personalized Immunotherapy 67 Cellerant 67 CureDM 67 Cara Therapeutics 67 Trophos 67 Alder Biopharmaceuticals 67 defensin mimetic antibiotic 67 Intarcia 67 AmpliMed 67 Merrimack Pharmaceuticals 67 GlycoMimetics 67 InNexus Biotechnology 67 Angiocept 67 Panzem R 67 Nereus Pharmaceuticals 67 Genome Therapeutics 67 Gentamicin Surgical Implant 67 Aegera 67 FluoroPharma 67 Epizyme 66 Sopherion 66 Albugon 66 Amplimmune 66 NKT Therapeutics 66 Factor VIIa 66 Idun Pharmaceuticals 66 Scancell 66 Immunotherapeutic 66 Cerenis Therapeutics 66 ViroChem 66 Virdante 66 Logical Therapeutics 66 Addrenex 66 Sunesis Pharmaceuticals 66 Initiates Phase II 66 mertansine 66 FOLOTYN ® 66 SYGNIS 66 ASONEP TM 66 Aileron Therapeutics 66 NeuroSolutions 66 MKC# MKC# PP 66 Avila Therapeutics 66 molecular imaging radiopharmaceutical 66 Excaliard 66 Alba Therapeutics 66 Exherin 66 EnzymeRx 66 Ascent Therapeutics 66 RxKinetix 66 OncoMed Pharmaceuticals 66 delivers fluocinolone acetonide FA 66 UltiMAb 66 Emisphere Technologies 66 Ridaforolimus 66 SynthRx 66 Anacor 66 Viamet Pharmaceuticals 66 OncoSec 66 VIRxSYS 66 NormOxys 66 ARRY # 66 BXT # 66 Leuchemix 66 Healionics 66 ProFibrix 66 Oxxon 66 Ibis Biosciences 66 REGiMMUNE 66 Ilypsa 66 Hoyoung Huh 66 Syndax 66 Cellgate 66 Quark Biotech Inc. 66 Idera Pharmaceuticals 66 Eyetech Pharmaceuticals 65 MT#/MEDI-# 65 Completes Patient Enrollment 65 MacroMed 65 Othera Pharmaceuticals Inc. 65 Cequent Pharmaceuticals 65 Chroma Therapeutics 65 Prism Pharmaceuticals 65 Chemokine Therapeutics 65 prostone 65 Zelos Therapeutics 65 Aflibercept 65 Naurex 65 Ambit Biosciences 65 EnVivo Pharmaceuticals 65 Athenagen 65 Initiates Clinical Trial 65 Raven Biotechnologies 65 Viamet 65 LEAD Therapeutics 65 Epiphany Biosciences 65 Nautilus Biotech 65 acetonide FA 65 Allovectin 7 65 Plexxikon 65 Zyngenia 65 Immunex Corporation 65 Genaera Corporation 65 Curaxin 65 Transave 65 Neuroptix 65 Lantibio 65 Ercole Biotech 65 Synergy Pharmaceuticals 65 Regeneron Pharma 65 Addrenex Pharmaceuticals 65 GVAX ® 65 Aegera Therapeutics 65 Litx 65 Amarantus 65 Juvaris BioTherapeutics 65 Cabrellis 65 Juvantia 65 Predix Pharmaceuticals 65 Chemokine 65 Initiates Enrollment 65 Silodosin 65 MEK inhibitor 65 Presidio Pharmaceuticals 65 Ziopharm 65 Fidelity Biosciences 65 Archemix Corp. 65 Tranzyme 65 Phase Ib clinical trials 65 Archexin 65 VLST 65 Receives Orphan Drug Designation 65 IL# PE#QQR 65 Regado Biosciences 65 Forma Therapeutics 65 outlicensed 65 LUCASSIN 65 Sirion Therapeutics 65 PharmaNova 65 NeuroHealing 65 Otonomy 65 TransTech Pharma 65 VIA Pharmaceuticals 65 PsychoGenics 65 Daclizumab 65 glucokinase activator 65 huC# DM4 65 Alantos 65 Ascenta Therapeutics 65 Alvine Pharmaceuticals 65 ActivBiotics 65 Kolltan Pharmaceuticals 65 dutogliptin 65 TESARO 65 Adamis Pharmaceuticals 65 Angiosyn 65 Acetylon 65 BioNumerik 65 Etubics 65 HaptoGuard 65 investigational humanized monoclonal antibody 65 Revotar 65 Cardioxyl Pharmaceuticals 65 Oncobionic 65 Fate Therapeutics 65 ALN PCS 65 Metaphore 65 Amphora Discovery 65 Acceleron Pharma 65 Squalamine 65 Salmedix 65 tiapamil 65 Akebia Therapeutics 65 Devax 65 ForSight Newco II 65 Scynexis 64 Oncolys 64 Expression Genetics 64 anti CD3 monoclonal 64 Orphan Therapeutics 64 MedImmune Ventures 64 KL4 Surfactant 64 oral prodrug 64 BiPar 64 liposomal formulation 64 OTCBB PYTO 64 Marinus Pharmaceuticals 64 Diatos 64 Receives Orphan Drug 64 Nasdaq PARD 64 Indaflex TM 64 ATG Fresenius S 64 Curagen 64 KuDOS 64 initiated Phase Ib 64 Akesis Pharmaceuticals 64 Novo Ventures 64 Sigma Tau Pharmaceuticals 64 Spray Venture Partners 64 Neurimmune 64 EVIZON TM 64 Conatus Pharmaceuticals 64 Harbor BioSciences 64 CeNeRx BioPharma 64 Phenomix 64 PhaseBio 64 DermTech 64 therapeutic monoclonal antibody 64 KaloBios Pharmaceuticals Inc. 64 Phase 1b clinical trials 64 Clarus Ventures 64 Novosom 64 ATL# [002] 64 miRagen 64 OGeS 64 docetaxel Taxotere R 64 Aganocide 64 SinuNase ™ 64 Altus Pharmaceuticals 64 P#X# antagonist 64 trastuzumab DM1 T DM1 64 anticancer compound 64 Vion Pharmaceuticals 64 HuMax TAC 64 Reata Pharmaceuticals 64 Evolva 64 ocular formulation 64 Cutanea 64 MacroGenics 64 Nitec 64 Amira Pharmaceuticals 64 Janssen Alzheimer Immunotherapy 64 DPX Survivac 64 Reports Preclinical Data 64 Hydra Biosciences 64 ProLindac TM 64 Locked Nucleic Acid 64 Liprotamase 64 IAP inhibitors 64 Maxy G# 64 Seikagaku 64 Alligator Bioscience AB 64 Initiates Phase III 64 Tranzyme Pharma 64 Stemgent 64 Apthera 64 Stromedix 64 Epitomics 64 OvaRex R 64 HepDirect 64 Nasdaq HALO 64 BLP# Liposome Vaccine 64 Locus Pharmaceuticals 64 Celladon Corporation 64 CureTech 64 GW# [003] 64 nicotinic alpha 7 64 Ceflatonin R 64 GammaCan 64 Nasdaq ACHN 64 Kinase Inhibitor 64 Archemix 64 Gastrotech 64 Alantos Pharmaceuticals 64 SuperAntibody 64 metaglidasen 64 epothilones 64 candidate deforolimus 64 pradefovir 64 Promedior 64 Phylogica 64 Galderma SA 64 c Raf kinase 64 TG# [003] 64 MacuSight 64 Milestone Payment 64 Euroscreen 64 Syntonix Pharmaceuticals 64 Avidia 64 Panzem R NCD 64 BioSeek 64 Calixa Therapeutics 64 Cetrorelix 64 L BLP# 64 Metastatix 64 SmartCells 64 Fresenius Biotech 64 Æterna Zentaris 64 BHT DNA 64 Alios BioPharma 64 hypoxia activated prodrug 64 product platforms AZX# 64 Tragara Pharmaceuticals Inc. 63 StromaCel Inc. 63 novel immunomodulatory 63 Hematide ™ 63 TetraLogic 63 Fujisawa Healthcare Inc. 63 Wellstat 63 Files IND 63 Lung Rx 63 THR beta agonist 63 ENMD # 63 Lixivaptan 63 ImmuneRegen BioSciences 63 Radius Ventures 63 HemaQuest 63 Nuon Therapeutics 63 Morphotek 63 Ore Pharmaceuticals 63 drug conjugate 63 developing TB4 63 Nexavar sorafenib 63 Supernus 63 Viventia 63 PRT# 63 Meritage Pharma 63 Ception Therapeutics 63 Psivida 63 BioRexis 63 Viralytics 63 Heartscape Technologies 63 Genospectra 63 Medgenics 63 Nventa Biopharmaceuticals 63 Orqis Medical 63 seliciclib CYC# 63 Systemic Delivery 63 RECOTHROM R 63 Receives Milestone Payment 63 atacicept 63 Cardioxyl 63 Elusys 63 Onconase 63 Napo Pharmaceuticals 63 CCR9 antagonist 63 Xanthus Pharmaceuticals Inc. 63 FORMA Therapeutics 63 Medidur ™ FA 63 Conforma 63 ASONEP 63 midstage trials 63 Nuron Biotech 63 Iluvien ® 63 Cenomed 63 Endotis 63 IMiD 63 Elixir Pharmaceuticals 63 Pharmion Corporation 63 Adnexus Therapeutics 63 Potelligent Technology 63 PNP inhibitor 63 Calixa 63 SARcode 63 outlicensing 63 ERYtech 63 Phase IIb clinical trials 63 WILEX 63 highly selective adenosine 63 Kosan dependence 63 proteasome inhibitor 63 Zentaris 63 Vernalis plc 63 Onalta 63 Endotis Pharma 63 Small Molecule 63 hypoxia selective 63 Argenta Discovery 63 Initiate Phase 63 Resolvyx 63 Hadasit Bio Holdings 63 Virosome Biologicals 63 Chiral Quest 63 SagaX 63 subsidiary Antigen Express 63 miRagen Therapeutics 63 CeNeRx 63 phase IIb clinical 63 Cytochroma 63 adenosine A2A 63 Ostabolin C TM 63 Zosano 63 5AM Ventures 63 Qutenza TM 63 Astex Therapeutics 63 HQK 63 MolecularMD 63 HepaLife 63 HepeX B 63 CoGenesys 63 IMC #F# 63 Biomarin 63 Phase 2b Clinical Trial 63 Amorcyte 63 Ceragenix 63 compound PMX # 63 VitiGam 63 CD# CEA 63 TRO# 63 KYTHERA Biopharmaceuticals Inc. 63 Tezampanel 63 OTCBB PYTO FWB ET6 63 ASX PGL 63 Afferent Pharmaceuticals 63 JAK2 Inhibitor 63 PLK1 SNALP 63 PANVAC VF 63 Prometheus Laboratories 63 Tacere 63 Insegia 63 Aurora kinase inhibitor 63 receptor tyrosine kinase inhibitor 63 GeneraMedix Inc. 63 drug pipeline TAFA# 63 fipamezole 63 Virium 63 Endovasc 63 PrevOnco 63 tubulin inhibitor 63 Enanta 63 Urokinase 63 Glufosfamide 63 AskBio 63 SansRosa 63 candidate iSONEP TM 63 OTCBB HXBM developer 63 MKC# MT 63 Enzon Pharmaceuticals 63 Inotek Pharmaceuticals 63 Proximagen 63 Nasdaq HALO biopharmaceutical 63 Nomura Phase4 Ventures 63 Hepregen 63 NOXXON 63 Astex 63 Advanced Magnetics 63 Helicon Therapeutics 63 XL# XL# 63 selective immunoproteasome inhibitor 63 Targeted Chemotherapy 63 Shigamabs ® 63 pralatrexate injection folate analogue 63 Lexicon Genetics 63 Robert L. Bratzler 63 Begins Dosing 63 Sanvar 63 Array BioPharma 63 BioVentures Investors 63 BiolineRX 63 AltaRex 63 Kiadis 63 Proprius Pharmaceuticals 63 anticancer therapeutics 63 Gliknik 63 GlobeImmune 63 AVEO Pharmaceuticals 63 XL# XL# XL# XL# 63 GPR# agonist 63 BioProcessors 63 Argatroban 63 Innate Pharma 63 Therapeutic Competitors Report 63 Prosensa 62 Nasdaq LEXG 62 LEUKINE 62 Probiodrug 62 Kazumi Shiosaki 62 adrenergic regulation 62 Calistoga Pharmaceuticals 62 KaloBios 62 KineMed 62 Genetronics 62 Arqule 62 Knopp Neurosciences 62 PureTech Ventures 62 elotuzumab 62 CombinatoRx Incorporated 62 TetraLogic Pharmaceuticals 62 Aurora Kinase 62 Arrow Therapeutics 62 InterfeRx 62 PhotoThera 62 HDAC Inhibitor 62 deforolimus 62 CoLucid 62 Successfully Completes Phase 62 Genetic Therapy 62 Tovaxin TM 62 Microfluidic Systems 62 Crofelemer budesonide foam 62 Alza Corporation 62 Neurome 62 Alfacell proprietary ribonuclease 62 Granted Orphan Drug 62 ChondroGene 62 adult mesenchymal stem 62 Avicena 62 IMiDs R 62 InfaCare 62 Cutanea Life Sciences 62 Quanterix 62 Adlyfe 62 AnaptysBio 62 Roche SIX RO 62 Civacir 62 Semprus BioSciences 62 ProNAi 62 AQ4N 62 small molecule glucokinase 62 OncoGel 62 CancerGuide 62 Immunotope 62 Altair Therapeutics 62 Pivotal Trial 62 Serenex 62 DermTech International 62 Graffinity 62 targeted antifolate 62 PDX pralatrexate 62 telomerase therapeutic 62 TKB# 62 danoprevir 62 CDP# 62 Zosano Pharma 62 KemPharm 62 Ironwood Pharmaceuticals 62 Nanobody ® 62 Proteo 62 Protalex Inc. 62 apricitabine ATC 62 MicroDose 62 molecular chaperone regulation 62 ORTHOCON 62 Idenix Pharmaceuticals 62 IMPACS R 62 Intellect Neurosciences 62 Tumour Vascular Disrupting Agent 62 Opko 62 TRACON Pharmaceuticals 62 Maribavir 62 Piramed 62 HistoRx 62 Aposense 62 romazarit 62 Panzem ® 62 EyeGate 62 Brussels THR 62 IAP inhibitor 62 initiated Phase 1b 62 beta secretase inhibitors 62 Cellzome 62 Verus Pharmaceuticals 62 Alnylam Nasdaq ALNY 62 PanGenetics 62 Aeolus Pharmaceuticals 62 GlycArt 62 DP VPA 62 EKR Therapeutics 62 Onalta TM 62 Cathepsin S 62 MedGenesis 62 Roche OTC RHHBY 62 Omacetaxine 62 Guanilib 62 NOBEX 62 Delenex 62 ProEthic Pharmaceuticals 62 Freedom Meditech 62 Mersana Therapeutics 62 ReVision Optics 62 Xencor 62 Anavex #-# 62 Bone Biologics 62 Serentis 62 Scil Proteins 62 Dicerna 62 mitogen activated ERK kinase 62 Antibody Drug Conjugate 62 Mipomersen 62 Mirna Therapeutics 62 Stanate R 62 Chipscreen 62 Xcyte 62 Selective Electrochemical Tumor Ablation 62 TRANSDUR ™ 62 Acologix 62 sublicensee 62 BioSyent Pharma 62 Garnet BioTherapeutics 62 Alnylam #x# 62 iCeutica 62 AtuRNAi 62 Ziopharm Oncology 62 novel histone deacetylase 62 Affibody 62 Therapeutic Competitors companiesandmarkets.com adEgemonye 62 HIV integrase inhibitor 62 EnVivo 62 Accentia Biopharmaceuticals 62 Anticancer Agent 62 Graffinity Pharmaceuticals 62 OHR/AVR# 62 Pacira 62 Cetek 62 NASDAQ RNAI 62 AMEX RGN 62 Carigent 62 ALN HPN 62 phase IIb trial 62 Aduro BioTech 62 selective androgen receptor modulator 62 Apitope 62 Furiex Pharmaceuticals 62 Charlesson 62 XL# anticancer compounds 62 t2cure GmbH 62 Acceleron 62 Senesco Technologies 62 Luveniq 62 HSP# inhibitor 62 Neutrolin ® 62 5 HT2A inverse 62 histone deacetylase HDAC inhibitor 62 topical anti infective 62 NASDAQ ALNY 62 SANOFI AVENTIS 62 Nasdaq OMER 62 Aveo Pharmaceuticals 62 BioOne 62 Anticalin R 62 ForSight Labs 62 IMC #B 62 Diasome 62 bluebird bio 62 Nasdaq VNDA 62 RegeneRx Biopharmaceuticals 62 Saladax Biomedical 62 Santaris 62 Sangamo BioSciences 62 Nanobody R 62 TELINTRA R 62 Intravenous Human 62 IV Busulfex 62 Sapacitabine 62 TRAIL receptor antibodies 62 Genotyping Test 62 polymerase inhibitor 62 Amplimexon 62 Lexicon Genetics Incorporated 62 TransMID 62 Novolimus 62 Biovitrum AB 62 StemEx 62 Viron Therapeutics 62 Phase #b/#a clinical 62 TRANSDUR Bupivacaine 62 Biotica 62 Genentech Roche 62 cancer immunotherapies 62 Stem Cell Innovations 62 Proxinium TM 62 Protox 62 Jaiva Technologies 62 inhaled formulation 62 tranilast 62 IMA# 62 Aganocide ® 62 Tesetaxel 62 Cempra Pharmaceuticals 62 AMPA kainate 62 Initiate Clinical Trial 62 PGL# 62 Spaltudaq 62 Neosil 62 oncolytic virus therapies 62 SCIB1 62 Syntaxin 62 Enanta Pharmaceuticals 62 PEGylated Fab fragment 62 Presents Preclinical Data 62 Cellerant Therapeutics 62 Catabasis 62 Avera Pharmaceuticals 62 Power3 Medical 62 Molecular Templates 62 orally bioavailable 62 SinuNase TM 62 PNT# 62 Genocea Biosciences 62 Cerimon Pharmaceuticals 62 Prima BioMed 62 Microbix Biosystems 62 NTDDS 62 Alnylam Pharmaceuticals Nasdaq ALNY 62 Myocet 62 ExonHit 62 MultiCell Technologies 62 lorvotuzumab mertansine 62 Pancreate 62 AcelRx 62 nitric oxide donating 62 Asentar TM 62 EVIZON TM squalamine lactate 62 Symphogen 62 Syrrx 62 ZEVALIN ® 62 Friedreich Ataxia FRDA 62 AnGes MG Inc. 62 OTCBB NRGX 62 Difimicin 62 Loramyc ™ 62 ADP receptor antagonist 62 Flamel Technologies 62 Romidepsin 62 Xytis 62 Inovio Pharmaceuticals 62 Xanafide 62 OncoTherapy Science 62 SAR# [004] 62 Meets Primary Endpoint 62 Peptimmune 62 Tyrima 62 SpineMedica 62 renin inhibitor 62 Adventrx 62 HuLuc# 62 NLV Partners 62 SYN X 62 CCX# 62 Yuval Cohen 62 entinostat 62 Carfilzomib 62 HuMax CD4 62 Alfacell 62 Onco TCS 62 Commence Phase 62 Nasdaq RXII 62 Sapphire Therapeutics 62 Numoda 62 POTELLIGENT ® 62 Ascentage Pharma 62 ImmunoGen TAP technology 62 CalciMedica 62 sodium glucose transporter 62 immunosuppressive compound 62 Teikoku Pharma USA 62 AAG geldanamycin analog 62 commercialize becocalcidiol patented 62 Clavis Pharma 62 BAY #-# 62 Tracon Pharmaceuticals 62 non nucleoside inhibitor 62 AC Immune 62 Oxis International 62 Corixa Corporation 62 Apexigen 61 Theraputics 61 ProtAffin 61 Akorn Strides 61 Kirsten Drejer 61 ZARS Pharma 61 RELOVAIR ™ 61 GeneICE 61 ImaRx Therapeutics 61 NeuroMedix 61 SoluBest 61 CoAxia 61 Presents Preclinical 61 AkaRx 61 DBV Technologies 61 Telatinib 61 Pimavanserin 61 Aestus Therapeutics 61 Lexicon Pharmaceuticals 61 Neurologix 61 Agenus 61 Tapestry Pharmaceuticals 61 Oncaspar 61 CR# vcMMAE 61 Solazed TM 61 CoMentis 61 Celladon 61 Lpath 61 lixivaptan 61 PhytoMedical 61 Xcytrin R 61 Santhera 61 highly selective inhibitor 61 IMiDs ® 61 Cardiokine 61 compound KOS 61 TLR9 agonist 61 Nastech Pharmaceutical Company 61 Innovive 61 Cylene 61 Nektar pulmonary 61 alvespimycin 61 Aquinox 61 Mpex 61 Awarded Qualifying Therapeutic 61 reslizumab 61 Agonist MABA program 61 AMEX INO 61 RTP #i 61 Tikvah Therapeutics 61 AviaraDx 61 Axordia 61 Sphingomab 61 Bellicum 61 Unit Dose Budesonide 61 biosurgical 61 vascular disrupting agents 61 NASDAQ OMER 61 multi kinase inhibitor 61 mGluR2 positive 61 dextromethorphan quinidine 61 Polyphor 61 VitiGam TM 61 DiscoveRx 61 XmAb# 61 Nasdaq CGEN 61 ImmunoCellular 61 Nanobody 61 oncolytic vaccine 61 Coley Pharmaceutical Group 61 NASDAQ PHRM 61 sulfonylhydrazine class 61 Opexa 61 Conforma Therapeutics 61 JAK2 inhibitor 61 Drug Candidate 61 CD# monoclonal antibody 61 novel immunotherapeutic 61 novel anti infective 61 Alethia Biotherapeutics 61 Lux Biosciences 61 Gelesis 61 NPS Pharma 61 Zenvia ™ 61 Helsinn 61 Aegerion 61 Advancis Pharmaceutical Corporation 61 HCV protease inhibitor 61 Phase 2b Trial 61 Eleven Biotherapeutics 61 Can Fite 61 Agenerase 61 Pervasis Therapeutics 61 QuatRx Pharmaceuticals 61 Saegis Pharmaceuticals 61 bardoxolone 61 BrachySil ™ 61 Edimer Pharmaceuticals 61 Medistem Laboratories 61 therapeutic monoclonal antibodies 61 novel peptides 61 AcuFocus 61 Halozyme Therapeutics 61 Diffusion Pharmaceuticals 61 CyDex Pharmaceuticals Inc. 61 recombinant subunit vaccine 61 Oncolin 61 KAHR Medical 61 BrainCells 61 Janssen AI 61 ParAllele 61 NeoGenesis 61 BioVex 61 Pevion 61 Vivecon 61 NPC 1C 61 MorphoSys proprietary 61 SomaLogic 61 iSONEP 61 GeneMax 61 Resolvyx Pharmaceuticals 61 TOPICA 61 Tepha 61 Transcept Pharmaceuticals 61 DiaPep# 61 EyeGate Pharma 61 Bicifadine 61 Trellis Bioscience 61 Itero 61 Apricus Biosciences 61 HyACT 61 Olaparib 61 BN ImmunoTherapeutics 61 MOVIPREP R 61 OMRIX Biopharmaceuticals Inc. 61 Igeneon 61 orally administered inhibitor 61 Therion Biologics Corporation 61 miRNA therapeutics 61 ForSight 61 iSONEP ™ 61 product Fentanyl TAIFUN 61 Phase 2b clinical trials 61 OTC BB PVCT 61 Synerx Pharma 61 Epeius Biotechnologies Corporation 61 Eric von Hofe 61 Bexion 61 Enhanze 61 selective kinase inhibitor 61 acyclovir Lauriad R 61 Locteron exclusively 61 developing Bicifadine serotonin 61 Genvec 61 AB OMXS BINV 61 Loramyc R 61 Myrexis 61 STEDESA 61 Chimigen TM 61 Dynogen Pharmaceuticals 61 investigational monoclonal antibody 61 VEGF Trap 61 MedPulser 61 RECOTHROM ® 61 Affimed 61 Paratek Pharmaceuticals Inc. 61 Corautus Genetics 61 Prochymal TM 61 Upstream Biosciences 61 evaluating satraplatin 61 PDL# 61 Annamycin